The role of PD-1 signaling in health and immune-related diseases

RY Chen, Y Zhu, YY Shen, QY Xu, HY Tang… - Frontiers in …, 2023 - frontiersin.org
Programmed cell death 1 receptor (PD-1) and its ligands constitute an inhibitory pathway to
mediate the mechanism of immune tolerance and provide immune homeostasis …

Clinical and molecular impact of concurrent thyroid autoimmune disease and thyroid cancer: From the bench to bedside

VA dos Santos Valsecchi, FR Betoni, LS Ward… - Reviews in Endocrine …, 2024 - Springer
The recent incorporation of immune checkpoint inhibitors targeting the PD-1 (programmed
cell death receptor 1) and CTLA-4 (cytotoxic T lymphocyte antigen 4) pathways into the …

Excretory/Secretory Products From Trichinella spiralis Adult Worms Attenuated DSS-Induced Colitis in Mice by Driving PD-1-Mediated M2 Macrophage Polarization

Z Wang, C Hao, Q Zhuang, B Zhan, X Sun… - Frontiers in …, 2020 - frontiersin.org
Helminth-modulated macrophages contribute to attenuating inflammation in inflammatory
bowel diseases. The programmed death 1 (PD-1) plays an important role in macrophage …

Single cell transcriptome and surface epitope analysis of ankylosing spondylitis facilitates disease classification by machine learning

S Alber, S Kumar, J Liu, ZM Huang, D Paez… - Frontiers in …, 2022 - frontiersin.org
Ankylosing spondylitis (AS) is an immune-mediated inflammatory disorder that primarily
affects the axial skeleton, especially the sacroiliac joints and spine. This results in chronic …

[HTML][HTML] PD-1/PD-L1 pathway: A double-edged sword in periodontitis

X Liu, L Yang, X Tan - Biomedicine & Pharmacotherapy, 2023 - Elsevier
Periodontitis is a disease caused by infection and immunological imbalance, which often
leads to the destruction of periodontal tissue. Programmed death protein 1 (PD-1) and its …

[HTML][HTML] Co-inhibitory molecules–their role in health and autoimmunity; highlighted by immune related adverse events

SR Greisen, M Aspari, B Deleuran - Frontiers in immunology, 2022 - frontiersin.org
Immune checkpoint receptors are key players in regulating the immune response. They are
responsible for both generating an immune response sufficient to kill invading pathogens …

The effect of combining PD-1 agonist and low-dose Interleukin-2 on treating systemic lupus erythematosus

B Wang, C Chen, X Liu, S Zhou, T Xu… - Frontiers in Immunology, 2023 - frontiersin.org
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease involving multiple
organs. It is often called “immortal cancer” due to the difficulties in disease treatment. As the …

[HTML][HTML] Bridging the gap: connecting the mechanisms of immune-related adverse events and autoimmunity through PD-1

A Mor, M Strazza - Frontiers in cell and developmental biology, 2022 - frontiersin.org
The emergence of anti–cytotoxic T-lymphocyte antigen 4 (anti-CTLA-4), anti–programmed
cell death 1 ligand (anti–PD-1), and anti–PD-L1 antibodies as immune checkpoint inhibitors …

[HTML][HTML] Investigation of the association between the genetic polymorphisms of the co-stimulatory system and systemic lupus erythematosus

DP Chen, WT Lin, KH Yu - Frontiers in Immunology, 2022 - frontiersin.org
Human leukocyte antigen genes have been shown to have the strongest association with
autoimmune disease (AD). However, non-HLA genes would be risk factors of AD. Many …

PD‐1 improves accurate detection of Sezary cells by flow cytometry in peripheral blood in mycosis fungoides/Sezary syndrome

NE Lewis, Q Gao, K Petrova‐Drus… - Cytometry Part B …, 2022 - Wiley Online Library
Abstract Background Accurate Sezary cell detection in peripheral blood of mycosis
fungoides/Sezary syndrome (MF/SS) patients by flow cytometry can be difficult due to …